Brain-type (B-type) natriuretic peptide (BNP) levels: truly cost-effective in diagnosis of congestive heart failure (CHF)? (In Consultation)

Citation metadata

Date: Jan. 2003
From: The Journal of Critical Illness(Vol. 18, Issue 1)
Publisher: CMP Medica, LLC
Document Type: Letter to the editor
Length: 473 words

Document controls

Main content

Article Preview :

To the editor:

I am an avid reader of your journal. In the November 2002 issue of The Journal of Critical illness I read with interest "Measuring BNP levels in the diagnosis and treatment of CHF." It was very informative, but it raised a few questions from my standpoint of internal medicine, which I hope will be clarified by the authors.

First of all, a diagnosis of CHF is more clinical than laboratory-based. Second, even if CHF is diagnosed on the basis of BNP levels, most physicians will obtain a chest film and an ECG to rule out any precipitating events. Furthermore, if CHF is a new diagnosis, a Doppler echocardiograph will be obtained as well. Taken together,...

Source Citation

Source Citation   

Gale Document Number: GALE|A97113781